Cash Flow Statement
Growth Metrics

Orthofix Medical (OFIX) Total Non-Current Liabilities (2010 - 2026)

Orthofix Medical (OFIX) reported Total Non-Current Liabilities of $395.3 million for Q1 2026, up 24.06% year-on-year from $318.6 million in Q1 2025, and up 14.6% quarter-over-quarter from $344.9 million in Q4 2025.

Orthofix Medical (OFIX) has 17 years of Total Non-Current Liabilities data on file, last reported at $395.3 million in Q1 2026.

  • For the quarter ending Q1 2026, Total Non-Current Liabilities rose 24.06% year-over-year to $395.3 million; the trailing twelve-month figure through Mar 2026 stood at $395.3 million (up 24.06% YoY), and the FY2025 full-year result was $344.9 million, down 7.96% from the prior year.
  • Total Non-Current Liabilities for Q1 2026 stood at $395.3 million, up from $344.9 million in the prior quarter.
  • Across five years, Total Non-Current Liabilities topped out at $395.3 million in Q1 2026 and bottomed at $97.1 million in Q3 2022.
  • A 5-year average of $266.7 million and a median of $318.1 million in 2023 frame the typical range for Total Non-Current Liabilities.
  • Across the five-year window, Total Non-Current Liabilities dropped 24.51% in 2022 and jumped 209.23% in 2023, its largest moves.
  • Tracing OFIX's Total Non-Current Liabilities over 5 years: stood at $102.9 million in 2022, then jumped by 209.23% to $318.1 million in 2023, then grew by 17.82% to $374.8 million in 2024, then fell by 7.96% to $344.9 million in 2025, then gained by 14.6% to $395.3 million in 2026.
  • According to Business Quant data, Total Non-Current Liabilities over the past three periods registered $395.3 million, $344.9 million, and $334.3 million for Q1 2026, Q4 2025, and Q3 2025 respectively.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Total Non-Current Liabilities (Qtr)
1 Abbott Laboratories 152.82 Bn 146.17 Bn 6.27 Bn -
2 Stryker 115.07 Bn 112.19 Bn 3.81 Bn 20.94 Bn
3 Medtronic 95.25 Bn 87.08 Bn 5.76 Bn 40.52 Bn
4 Boston Scientific 71.38 Bn 70.17 Bn 3.61 Bn 15.78 Bn
5 Edwards Lifesciences 51.08 Bn 47.41 Bn 1.29 Bn 2.44 Bn
6 Koninklijke Philips 29.38 Bn 26.07 Bn 2.07 Bn 9.85 Bn
7 Dexcom 28.84 Bn 27.72 Bn 750.30 Mn 3.53 Bn
8 GE HealthCare Technologies 28.56 Bn 26.49 Bn 1.98 Bn 24.21 Bn
9 Steris 20.71 Bn 20.30 Bn 697.10 Mn 3.47 Bn
10 Orthofix Medical 375.38 Mn 254.51 Mn 139.55 Mn 395.31 Mn

Historic Data

Download Data 🔒
DateValue
Mar 31, 2026 395.31 Mn
Dec 31, 2025 344.93 Mn
Sep 30, 2025 334.31 Mn
Jun 30, 2025 368.81 Mn
Mar 31, 2025 318.64 Mn
Dec 31, 2024 374.77 Mn
Sep 30, 2024 333.35 Mn
Jun 30, 2024 287.44 Mn
Mar 31, 2024 328.04 Mn
Dec 31, 2023 318.09 Mn
Sep 30, 2023 241.25 Mn
Jun 30, 2023 254.50 Mn
Mar 31, 2023 201.64 Mn
Dec 31, 2022 102.86 Mn
Sep 30, 2022 97.06 Mn
Jun 30, 2022 118.72 Mn
Mar 31, 2022 114.72 Mn
Dec 31, 2021 122.49 Mn
Sep 30, 2021 100.05 Mn
Jun 30, 2021 132.43 Mn
Mar 31, 2021 151.96 Mn
Dec 31, 2020 133.60 Mn
Sep 30, 2020 155.94 Mn
Jun 30, 2020 244.96 Mn
Mar 31, 2020 132.92 Mn
Dec 31, 2019 125.29 Mn
Sep 30, 2019 164.67 Mn
Jun 30, 2019 88.83 Mn
Mar 31, 2019 131.73 Mn
Dec 31, 2018 85.91 Mn
Sep 30, 2018 123.32 Mn
Jun 30, 2018 63.94 Mn
Mar 31, 2018 65.18 Mn
Dec 31, 2017 79.41 Mn
Sep 30, 2017 74.07 Mn
Jun 30, 2017 65.10 Mn
Mar 31, 2017 62.87 Mn
Dec 31, 2016 83.44 Mn
Sep 30, 2016 83.28 Mn
Jun 30, 2016 77.20 Mn
Mar 31, 2016 59.00 Mn
Dec 31, 2015 81.99 Mn
Sep 30, 2015 78.58 Mn
Jun 30, 2015 64.91 Mn
Mar 31, 2015 69.41 Mn
Dec 31, 2014 8.11 Mn
Sep 30, 2014 94.27 Mn
Jun 30, 2014 116.42 Mn
Mar 31, 2014 90.92 Mn
Dec 31, 2013 8.11 Mn
Sep 30, 2013 96.38 Mn
Jun 30, 2013 103.85 Mn
Mar 31, 2013 92.75 Mn
Dec 31, 2012 8.11 Mn
Sep 30, 2012 190.53 Mn
Jun 30, 2012 204.65 Mn
Mar 31, 2012 378.84 Mn
Dec 31, 2011 8.11 Mn
Sep 30, 2011 344.69 Mn
Jun 30, 2011 345.71 Mn
Dec 31, 2010 8.11 Mn